BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8552091)

  • 1. BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes.
    Peyton M; Stellrecht CM; Naya FJ; Huang HP; Samora PJ; Tsai MJ
    Mol Cell Biol; 1996 Feb; 16(2):626-33. PubMed ID: 8552091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor.
    Naya FJ; Stellrecht CM; Tsai MJ
    Genes Dev; 1995 Apr; 9(8):1009-19. PubMed ID: 7774807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct class A helix-loop-helix transcription factors, E2A and BETA1, form separate DNA binding complexes on the insulin gene E box.
    Peyton M; Moss LG; Tsai MJ
    J Biol Chem; 1994 Oct; 269(41):25936-41. PubMed ID: 7929299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription.
    Thomas MK; Yao KM; Tenser MS; Wong GG; Habener JF
    Mol Cell Biol; 1999 Dec; 19(12):8492-504. PubMed ID: 10567574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene.
    Qiu Y; Sharma A; Stein R
    Mol Cell Biol; 1998 May; 18(5):2957-64. PubMed ID: 9566915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2.
    Dumonteil E; Laser B; Constant I; Philippe J
    J Biol Chem; 1998 Aug; 273(32):19945-54. PubMed ID: 9685329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of BETA2/NeuroD by Id2.
    Ghil SH; Jeon YJ; Suh-Kim H
    Exp Mol Med; 2002 Nov; 34(5):367-73. PubMed ID: 12526101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human P2X1 promoter activity by beta helix-loop-helix factors in smooth muscle cells.
    Dhulipala PD; Lianos EA; Kotlikoff MI
    Gene; 2001 May; 269(1-2):167-75. PubMed ID: 11376948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the bHLH domains of MyoD-E47 heterodimer.
    Zhong J; Jin Z; Jiang L; Zhang L; Hu Z; Zhang Y; Liu Y; Ma J; Huang Y
    Biochem Biophys Res Commun; 2022 Sep; 621():88-93. PubMed ID: 35810596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity.
    Skerjanc IS; Truong J; Filion P; McBurney MW
    J Biol Chem; 1996 Feb; 271(7):3555-61. PubMed ID: 8631961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter.
    Sigvardsson M
    Mol Cell Biol; 2000 May; 20(10):3640-54. PubMed ID: 10779354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD.
    Kim JY; Chu K; Kim HJ; Seong HA; Park KC; Sanyal S; Takeda J; Ha H; Shong M; Tsai MJ; Choi HS
    Mol Endocrinol; 2004 Apr; 18(4):776-90. PubMed ID: 14752053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors.
    Azmi S; Ozog A; Taneja R
    J Biol Chem; 2004 Dec; 279(50):52643-52. PubMed ID: 15448136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel class II bHLH transcription factor from the black widow spider, Latrodectus hesperus, with silk-gland restricted patterns of expression.
    Kohler K; Thayer W; Le T; Sembhi A; Vasanthavada K; Moore AM; Vierra CA
    DNA Cell Biol; 2005 Jun; 24(6):371-80. PubMed ID: 15941389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.
    Lenormand JL; Benayoun B; Guillier M; Vandromme M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1997 Feb; 17(2):584-93. PubMed ID: 9001211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD.
    Lemercier C; To RQ; Carrasco RA; Konieczny SF
    EMBO J; 1998 Mar; 17(5):1412-22. PubMed ID: 9482738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-mediated folding and assembly of MyoD-E47 heterodimers.
    Wendt H; Thomas RM; Ellenberger T
    J Biol Chem; 1998 Mar; 273(10):5735-43. PubMed ID: 9488706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.
    Petropoulos H; Skerjanc IS
    J Biol Chem; 2000 Aug; 275(33):25095-101. PubMed ID: 10833525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer-specific modulation of E protein activity.
    Markus M; Du Z; Benezra R
    J Biol Chem; 2002 Feb; 277(8):6469-77. PubMed ID: 11724804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymyositis-scleroderma autoantigen interacts with the helix-loop-helix proteins E12 and E47.
    Kho CJ; Huggins GS; Endege WO; Patterson C; Jain MK; Lee ME; Haber E
    J Biol Chem; 1997 May; 272(20):13426-31. PubMed ID: 9148967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.